Elevated FMR1 mRNA in premutation carriers is due to increased transcription

RNA

Volumn 13, Issue 4, 2007, Pages 555-562

  Tassone, Flora ^a,b   Beilina, Alexandra ^a   Carosi, Chiara ^c,d   Albertosi, Serena ^d   Bagni, Claudia ^c,d   Li, Lexin ^a   Glover, Kira ^e   Bentley, David ^e   Hagerman, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

AGG; Fragile X; FXTAS; Nuclear run on; RNA toxicity; Transcription rate

Indexed keywords

DIGOXIGENIN; FRAGILE X MENTAL RETARDATION PROTEIN;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLELES; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HETEROZYGOTE; LEUKOCYTES, MONONUCLEAR; NERVE TISSUE PROTEINS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33947722883     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.280807     Document Type: Article

References (40)

1. Allen, E.G., He, W., Yadav-Shah, M., and Sherman, S.L. 2004. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum. Genet. 114: 439-447.
2. Allingham-Hawkins, D.J., Babul-Hirji, R., Chitayat, D., Holden, J.J., Yang, K.T., Lee, C., Hudson, R., Gorwill, H., Nolin, S.L., Glicksman, A., et al. 1999. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study-preliminary data. Am. J. Med. Genet. 83: 322-325.
3. Arocena, D.G., Iwahashi, C.K., Won, N., Beilina, A., Ludwig, A.L., Tassone, F., Schwartz, P.H., and Hagerman, P.J. 2005. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum. Mol. Genet. 14: 3661-3671.
4. Beilina, A., Tassone, F., Schwartz, P.H., Sahota, P., and Hagerman, P.J. 2004. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum. Mol. Genet. 13: 543-549.
5. Chen, L.S., Tassone, F., Sahota, P., and Hagerman, P.J. 2003. The (CGG)n repeat element within the 5′ untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum. Mol. Genet. 12: 3067-3074.
6. Coppola, J.A., Field, A.S., and Luse, D.S. 1983. Promoter-proximal pausing by RNA polymerase II in vitro: Transcripts shorter than 20 nucleotides are not capped. Proc. Natl. Acad. Sci. 80: 1251-1255.
7. Dombrowski, C., Levesque, S., Morel, M.L., Rouillard, P., Morgan, K., and Rousseau, F. 2002. Premutation and intermediate-size FMR1 alleles in 10,572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum. Mol. Genet. 11: 371-378.
8. Eichler, E.E., Holden, J.J., Popovich, B.W., Reiss, A.L., Snow, K., Thibodeau, S.N., Richards, C.S., Ward, P.A., and Nelson, D.L. 1994. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat. Genet. 8: 88-94.
9. Finsterer, J. 2002. Myotonic dystrophy type 2. Eur. J. Neurol. 9: 441-447.
10. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick Jr., R.G., Warren, S.T., et al. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67: 1047-1058.
11. Greco, C.M., Hagerman, R.J., Tassone, F., Chudley, A.E., Del Bigio, M.R., Jacquemont, S., Leehey, M., and Hagerman, P.J. 2002. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125: 1760-1771.
12. Greco, C.M., Berman, R.F., Martin, R.M., Tassone, F., Schwartz, P.H., Chang, A., Trapp, B.D., Iwahashi, C., Brunberg, J., Grigsby, J., et al. 2006. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129: 243-255.
13. Greenberg, M. and Bender, T. 1997. Nuclear runoff transcription in mammalian cells. Curr. Prot. Molec. Bio. Supp. 37: 4.10.11-14.10.11.
14. Hagerman, P.J. and Hagerman, R.J. 2004. The fragile-X premutation: A maturing perspective. Am. J. Hum. Genet. 74: 805-816.
15. Hagerman, R.J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B., and Hagerman, P.J. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57: 127-130.
16. Ho, T.H., Charlet, B.N., Poulos, M.G., Singh, G., Swanson, M.S., and Cooper, T.A. 2004. Muscleblind proteins regulate alternative splicing. EMBO J. 23: 3103-3112.
17. Jacquemont, S., Hagerman, R.J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J.A., Greco, C., Des Portes, V., Jardini, T., Levine, R., et al. 2003. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet. 72: 869-878.
18. Jacquemont, S., Hagerman, R.J., Leehey, M.A., Hall, D.A., Levine, R.A., Brunberg, J.A., Zhang, L., Jardini, T., Gane, L.W., Harris, S.W., et al. 2004. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291: 460-469.
19. Jin, P., Zarnescu, D.C., Zhang, F., Pearson, C.E., Lucchesi, J.C., Moses, K., and Warren, S.T. 2003. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39: 739-747.
20. Kanadia, R.N., Johnstone, K.A., Mankodi, A., Lungu, C., Thornton, C.A., Esson, D., Timmers, A.M., Hauswirth, W.W., and Swanson, M.S. 2003. A muscleblind knockout model for myotonic dystrophy. Science 302: 1978-1980.
21. Kenneson, A., Zhang, F., Hagedorn, C.H., and Warren, S.T. 2001. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 10: 1449-1454.
22. Kunst, C.B. and Warren, S.T. 1994. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell 77: 853-861.
23. Mankodi, A. and Thornton, C.A. 2002. Myotonic syndromes. Curr. Opin. Neurol. 15: 545-552.
24. Marozzi, A., Vegetti, W., Manfredini, E., Tibiletti, M.G., Testa, G., Crosignani, P.G., Ginelli, E., Meneveri, R., and Dalpra, L. 2000. Association between idiopathic premature ovarian failure and fragile X premutation. Hum. Reprod. 15: 197-202.
25. McCracken, S., Fong, N., Rosonina, E., Yankulov, K., Brothers, G., Siderovski, D., Hessel, A., Foster, S., Shuman, S., and Bentley, D.L. 1997. 5′-capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes & Dev. 11: 3306-3318.
26. Napierala, M., Bacolla, A., and Wells, R.D. 2005. Increased negative superhelical density in vivo enhances the genetic instability of triplet repeat sequences. J. Biol. Chem. 280: 37366-37376.
27. Oostra, B.A. and Willemsen, R. 2003. A fragile balance: FMR1 expression levels. Hum. Mol. Genet. 12: R249-R257.
28. Pearson, C.E., Eichler, E.E., Lorenzetti, D., Kramer, S.F., Zoghbi, H.Y., Nelson, D.L., and Sinden, R.R. 1998. Interruptions in the triplet repeats of SCA1 and FRAXA reduce the propensity and complexity of slipped strand DNA (S-DNA) formation. Biochemistry 37: 2701-2708.
29. Primerano, B., Tassone, F., Hagerman, R.J., Hagerman, P., Amaldi, F., and Bagni, C. 2002. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 8: 1482-1488.
30. Ranum, L.P. and Day, J.W. 2004. Myotonic dystrophy: RNA pathogenesis comes into focus. Am. J. Hum. Genet. 74: 793-804.
31. Saluto, A., Brussino, A., Tassone, F., Arduino, C., Cagnoli, C., Pappi, P., Hagerman, P., Migone, N., and Brusco, A. 2005. An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J. Mol. Diagn. 7: 605-612.
32. Snow, K., Tester, D.J., Kruckeberg, K.E., Schaid, D.J., and Thibodeau, S.N. 1994. Sequence analysis of the fragile X trinucleotide repeat: Implications for the origin of the fragile X mutation. Hum. Mol. Genet. 3: 1543-1551.
33. Tassone, F., Hagerman, R.J., Iklé, D.N., Dyer, P.N., Lampe, M., Willemsen, R., Oostra, B.A., and Taylor, A.K. 1999. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am. J. Med. Genet. 84: 250-261.
34. Tassone, F., Hagerman, R.J., Chamberlain, W.D., and Hagerman, P.J. 2000a. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am. J. Med. Genet. 97: 195-203.
35. Tassone, F., Hagerman, R.J., Loesch, D.Z., Lachiewicz, A., Taylor, A.K., and Hagerman, P.J. 2000b. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am. J. Med. Genet. 94: 232-236.
36. Tassone, F., Hagerman, R.J., Taylor, A.K., Gane, L.W., Godfrey, T.E., and Hagerman, P.J. 2000c. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66: 6-15.
37. Tassone, F., Hagerman, R.J., Garcia-Arocena, D., Khandjian, E.W., Greco, C.M., and Hagerman, P.J. 2004a. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J. Med. Genet. 41: e43.
38. Tassone, F., Iwahashi, C., and Hagerman, P.J. 2004b. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol. 1: 103-105.
39. Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., and Bagni, C. 2003. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112: 317-327.
40. Zhong, N., Ye, L., Dobkin, C., and Brown, W.T. 1994. Fragile X founder chromosome effects: Linkage disequilibrium or microsatellite heterogeneity? Am. J. Med. Genet. 51: 405-411.